Patients in both repaglinide and metformin groups achieved significant reductions in HbA@c ( -@ @ vs -@ @ % ) , FPG ( fasting blood glucose ) ( -@ @ vs -@ @ mmol/l ) and @-hPPG ( post-prandial glucose ) ( -@ @ vs -@ @ mmol/l ) , with no statistical differences between the groups .